Empowered Patient Podcast

Henry O'Connell is the CEO and Co-Founder of Canary Speech, which analyzes voice biomarkers to detect various medical conditions, including neurological disorders like Alzheimer's, Parkinson's, and cognitive decline. Their approach looks at the underlying mechanisms of speech controlled by the central nervous system rather than the words spoken. The technology has been validated to correlate with clinical diagnoses at a high accuracy level. It provides real-time, objective assessments to healthcare providers, which could help overcome biases and reveal early signs of the presence of a disease. Henry explains, "Canary Speech is now about eight years old. Jeff Adams, my business partner and friend, and I created Canary Speech to evaluate voice for a range of different human conditions and diseases. We actually established an approach that was unique in the market. Jeff has a history of innovation in voice and voice analysis. He was the lead that developed the first natural language processing commercial tools.